Ongoing Clinical Trials Numerous questions remain under investigation, including: Long-term biological effects Extended safety profiles Pharmacodynamic characteristics Receptor-level adaptations Combination therapy applications As a result, ongoing clinical trials continue to generate new information regarding the compounds biological activity and potential future applications
This solution contains 500 g/mL of Levocarnitine and 2.5 g/mL of added potassium from the Standard solution
received honoraria for speaking at meetings from Novartis, Sanofi-Aventis, Lilly, AstraZeneca, Boehringer Ingelheim, and NovoNordisk
Glutathione, also known as GSH, is an antioxidant made from three amino acids, glutamic acid, cysteine, and glycine
Why did the Phase I trial get cancelled
Proceedings of the SCSK Conference (2003)